References
Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression. Lancet 2023, 401: 141–153.
Li Z, Ruan M, Chen J, Fang Y. Major depressive disorder: Advances in neuroscience research and translational applications. Neurosci Bull 2021, 37: 863–880.
Brechmann T, Maier C, Kaisler M, Vollert J, Schmiegel W, Pak S. Propofol sedation during gastrointestinal endoscopy arouses euphoria in a large subset of patients. United European Gastroenterol J 2018, 6: 536–546.
Jiang Y, Zou M, Wang Y, Wang Y. Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review. Brain Res Bull 2023, 196: 68–75.
Zhu XN, Li J, Qiu GL, Wang L, Lu C, Guo YG, et al. Propofol exerts anti-anhedonia effects via inhibiting the dopamine transporter. Neuron 2023, 111: 1626-1636.e6.
Nagata I, Sasaki M, Miyazaki T, Saeki K, Ogawa KI, Kamiya Y. Subanesthetic dose of propofol activates the reward system in rats. Anesth Analg 2022, 135: 414–426.
Luo J, Min S, Wei K, Cao J, Wang B, Li P, et al. Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression. Neuropsychiatr Dis Treat 2014, 10: 1847–1859.
Castro DC, Bruchas MR. A motivational and neuropeptidergic hub: Anatomical and functional diversity within the nucleus accumbens shell. Neuron 2019, 102: 529–552.
Walsh JJ, Han MH. The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context. Neuroscience 2014, 282: 101–108.
Park YS, Sammartino F, Young NA, Corrigan J, Krishna V, Rezai AR. Anatomic review of the ventral capsule/ventral Striatum and the nucleus accumbens to guide target selection for deep brain stimulation for obsessive-compulsive disorder. World Neurosurg 2019, 126: 1–10.
Lee Y, Subramaniapillai M, Brietzke E, Mansur RB, Ho RC, Yim SJ, et al. Anti-cytokine agents for anhedonia: Targeting inflammation and the immune system to treat dimensional disturbances in depression. Ther Adv Psychopharmacol 2018, 8: 337–348.
Pan Z, Park C, Brietzke E, Zuckerman H, Rong C, Mansur RB, et al. Cognitive impairment in major depressive disorder. CNS Spectr 2019, 24: 22–29.
Liu P, Zhao S, Qiao H, Li T, Mi W, Xu Z, et al. Does propofol definitely improve postoperative cognitive dysfunction? A review of propofol-related cognitive impairment. Acta Biochim Biophys Sin 2022, 54: 875–881.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yan, Y., Ma, H. & Zhao, J. Propofol Brings on the Light for Depression Therapy. Neurosci. Bull. 39, 1891–1894 (2023). https://doi.org/10.1007/s12264-023-01133-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-023-01133-7